In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
GE acquires Amersham for $9.5 billion
Corixa and GSK announce FDA approval of BEXXAR
Amersham Pharmacia signs marketing agreement with Biofocus
Amersham Pharmacia to license Orchid's primer extension technology
Corixa announces sale and transfer of BEXXAR development and marketing rights to GlaxoSmithKline
Amersham, Galil Medical Joint Venture
Amersham acquires virus inactivation technology
Amersham signs license agreements for Green Fluorescent Proteins